PIQRAY 150 mg/1 (Alpelisib TABLET) 150 mg/1

PIQRAY 150 mg tablets are a pharmaceutical product used for specific medical conditions. This oral medication is manufactured by Novartis Pharmaceuticals Corporation in the USA.

Strength

150 mg/1

Pack Size

1 BLISTER PACK in 1 CARTON (0078-0708-91) / 28 TABLET in 1 BLISTER PACK (0078-0708-90)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PIQRAY 150 mg tablets are generally used in the treatment of certain types of cancer. The primary use of PIQRAY is often in combination with other therapies to target specific genetic mutations. Patients and healthcare providers typically discuss the specific uses of PIQRAY based on individual health profiles.

Side Effects

Common effects of PIQRAY 150 mg tablets may include gastrointestinal issues, skin reactions, and changes in blood sugar levels. Some users might experience fatigue or appetite changes. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent.

Precautions & Warnings

PIQRAY 150 mg tablets should be handled with care, following the guidelines provided by a healthcare professional. It is essential to store the medication properly and adhere to the prescribed usage. Patients with certain medical conditions or allergies should inform their healthcare provider before starting PIQRAY.

Avoid Interactions

PIQRAY 150 mg tablets may interact with other medications, including those that affect liver enzymes. It is advisable to avoid alcohol while using PIQRAY, as it may exacerbate certain side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

PIQRAY is typically used in the treatment of certain types of cancer, often in combination with other therapies.

PIQRAY is an oral medication that should be taken as directed by a healthcare provider.

Common side effects may include gastrointestinal issues, skin reactions, and changes in blood sugar levels.

PIQRAY may interact with other medications, so it's important to consult a healthcare provider before combining treatments.

PIQRAY should be stored according to the instructions provided by the manufacturer and healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.